Kinomica
1 known investors
Kinomica develops KScan, a phosphoproteomic diagnostic platform that analyzes which proteins and signaling pathways are activated to guide treatment selection for patients and support the discovery of new drug targets. The company focuses on precision medicine and response-to-treatment diagnostics.
Investors · 1
Frequently asked questions
- What does Kinomica do?
- Kinomica develops KScan, a phosphoproteomic diagnostic platform that analyzes which proteins and signaling pathways are activated to guide treatment selection for patients and support the discovery of new drug targets. The company focuses on precision medicine and response-to-treatment diagnostics.
- Who are Kinomica's investors?
- Kinomica's investors include Longwall Venture Partners LLP.